| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
BHVN
Biohaven Ltd.
|
May 27, 2026 | HOLD |
Strong Buy
+87.5% avg upside
25 analysts
|
$12.00
11.59% Downside
|
+20.2% |
|
VERA
Vera Therapeutics
|
May 22, 2026 | BUY |
Strong Buy
+91.0% avg upside
19 analysts
|
$65.00
85.22% Upside
|
-5.1% |
|
PROK
ProKidney
|
May 18, 2026 | SELL |
Buy
+261.9% avg upside
12 analysts
|
$1.00
45.27% Downside
|
· |
|
AMLX
Amylyx Pharmaceuticals Inc
|
May 07, 2026 | BUY |
Strong Buy
+46.8% avg upside
13 analysts
|
$22.00
40.36% Upside
|
+1.1% |
|
CPRX
Catalyst Pharma
|
Apr 27, 2026 | BUY |
Strong Buy
-17.0% avg upside
15 analysts
|
$35.00
11.60% Upside
|
+7.3% |
|
IMVT
Immunovant
|
Feb 06, 2026 | BUY |
Strong Buy
+9.0% avg upside
24 analysts
|
$32.00
9.44% Downside
|
+28.3% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.